---
schema_version: "secwatch.filing_event.v1"
accession: "0000914475-25-000139"
form_type: "8-K"
ticker: "NBIX"
cik: "0000914475"
company_name: "NEUROCRINE BIOSCIENCES INC"
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T05:19:28.238043+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Neurocrine CMO Eiry Roberts to step down; Sanjay Keswani named successor June 2, 2025

## Summary
- Dr. Eiry Roberts transitions from CMO to Strategic Advisor to the CEO, effective June 2, 2025 through Dec 31, 2025.
- Dr. Sanjay Keswani will succeed Dr. Roberts as Chief Medical Officer, effective June 2, 2025.
- Dr. Roberts receives annual base salary of $731,400 and target bonus of 60% of base pay in new advisory role.
- Outstanding equity awards continue vesting; severance terms substantially unchanged from prior agreement.

## SEC filing metadata
- accession: 0000914475-25-000139
- form_type: 8-K
- ticker: NBIX
- cik: 0000914475
- company_name: NEUROCRINE BIOSCIENCES INC
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/914475/000091447525000139/0000914475-25-000139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/914475/000091447525000139/nbix-20250530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000914475-25-000139
- JSON: https://secwatch.observer/filing/0000914475-25-000139.json
- Plain text: https://secwatch.observer/filing/0000914475-25-000139.txt

## Key facts
- Executive change
  Eiry W. Roberts changed role as Strategic Advisor to the CEO at NEUROCRINE BIOSCIENCES INC.
  - Action: transitioned
  - Role: Strategic Advisor to the CEO
  source text: Sanjay Keswani, M.D. will succeed Eiry W. Roberts, M.D. as the Chief Medical Officer of the Company, effective June 2, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447525000139/0000914475-25-000139-index.htm
- Executive change
  Sanjay Keswani was appointed as Chief Medical Officer at NEUROCRINE BIOSCIENCES INC.
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Sanjay Keswani, M.D. will succeed Eiry W. Roberts, M.D. as the Chief Medical Officer of the Company, effective June 2, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/914475/000091447525000139/0000914475-25-000139-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.